PerkinElmer Unveils Industry-first Cell Analysis Solution to Streamline Cell and Gene Therapy Research and Manufacturing

PR Teaser: WALTHAM, Mass.--(BUSINESS WIRE)-- PerkinElmer, Inc., (NYSE: PKI), a global leader committed to innovating for a healthier world, today launched the Cellaca® PLX Image Cytometry System, a first-of-its-kind benchtop platform that enables researchers to assess multiple Critical Quality Attributes (CQAs) of cell samples in a single automated workflow, including cell identity, quality and quantity. Read the full press release »

By |2022-10-05T14:36:42+00:00September 26th, 2022|Categories: Company News|0 Comments

The Cellaca MX High-throughput Cell Counter from Nexcelom Bioscience has been nominated for a Scientists’ Choice Award

We are delighted to announce that, thanks to our loyal customers, the Cellaca™ MX High-throughput Cell Counter has been nominated in the Life Sciences category.

By |2021-06-15T04:19:36+00:00April 21st, 2020|Categories: Cellaca, Company News, Instrument, Latest News|Tags: , |0 Comments

Nexcelom Bioscience Launches the Cellaca™ MX at AACR

Nexcelom Bioscience, a leading provider of cell counting and characterization products for the life science industry, announced the launch of the revolutionary high throughput, high-speed automated cell counter – Cellaca™ MX.

By |2021-06-15T04:28:39+00:00April 1st, 2019|Categories: Company News, Latest News, Upcoming Events|Tags: , |0 Comments

Nexcelom Bioscience announces strategic growth investment from Ampersand Capital Partners

The latest news from Nexcelom Bioscience March 20, 2018 - Nexcelom Bioscience announces strategic growth investment from Ampersand Capital Partners (PDF) March 20, 2018, Lawrence, MA -- Nexcelom Bioscience, a leading provider of cell counting and analysis products for biomedical research and the biopharma industry, announced today that it has received a strategic investment from Ampersand Capital Partners.  The funding will be primarily used to support Nexcelom’s worldwide growth initiatives. Founded in 2003, Nexcelom is a fast-growing supplier of innovative cellular analysis instruments, software and related consumables used in a broad range of research fields including immuno-oncology, cell therapy, drug discovery, [...]

By |2018-06-05T17:29:56+00:00March 20th, 2018|Categories: Company News|0 Comments

Nexcelom to hold inaugural Celigo user group meeting in London, February 2016

On February 9, 2016 at the Institute for Cancer Research, Chelsea, London, UK, Nexcelom will be holding an inaugural Celigo user group meeting, free to anyone who would like to attend. Celigo users from the pharmaceutical, academic, and biotech sectors will be present to discuss their research with this instrument. Speakers will include: Dr. Daniel Paull – NYSCF Dr. Maria Vinci – ICR Dr. Urs Senn – ETH Zurich Dr. Henning Gram Hansen – DTU Dr. Thilo Riedl – Genmab Dr. Valerie LeFourn – Selexis Dr. Christian Muller – Universite de Strasbourg The Celigo is a best-in-class image cytometer, with [...]

By |2021-06-15T19:16:57+00:00January 12th, 2016|Categories: Company News, General Discussions|Tags: |0 Comments
Go to Top